focus on shock

74
Focus on Shock (Relates to Chapter 67, “Nursing Management: Shock and Multiple Organ Dysfunction Syndrome,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Upload: others

Post on 09-May-2022

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Focus on Shock

Focus on Shock

(Relates to Chapter 67, “Nursing Management: Shock and Multiple Organ Dysfunction Syndrome,” in the textbook)

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 2: Focus on Shock

2

Shock

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 3: Focus on Shock

3

Shock

Classification of shock

Cardiogenic HypovolemicDistributiveObstructive

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 4: Focus on Shock

4

Low Blood FlowCardiogenic Shock Definition:

Systolic or diastolic dysfunction Compromised cardiac output (CO)

Precipitating causes: MI Cardiomyopathy Blunt cardiac injury Severe systemic or pulmonary hypertension Cardiac Tamponade Myocardial depression from metabolic

problems Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 5: Focus on Shock

Pathophysiology of Cardiogenic Shock

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 5

Fig. 67-1. Relationship of shock, systemic inflammatory response syndrome, and multiple

organ ­dysfunction syndrome. CNS, Central nervous system.

Page 6: Focus on Shock

6

Low Blood FlowCardiogenic Shock

Early manifestations TachycardiaHypotensionNarrowed pulse pressure ↑ myocardial O2 consumption

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 7: Focus on Shock

7

Low Blood FlowCardiogenic Shock

Physical examination Tachypnea, pulmonary congestion Pallor; cool, clammy skinDecreased capillary refill timeAnxiety, confusion, agitation

↑ in pulmonary artery wedge pressure Decreased renal perfusion and UO

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 8: Focus on Shock

8

Low Blood FlowHypovolemic Shock

Absolute hypovolemia: Loss of intravascular fluid volume

HemorrhageGI loss (e.g., vomiting, diarrhea) Fistula drainageDiabetes insipidusHyperglycemiaDiuresis

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 9: Focus on Shock

9

Low Blood FlowHypovolemic Shock

Relative hypovolemia fluid volume moves out of the vascular

space into extravascular space (e.g., interstitial or intracavitary space)

Termed third spacing

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 10: Focus on Shock

Pathophysiology of Hypovolemic Shock

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 10

Fig. 67-3. The pathophysiology of hypovolemic shock.

Page 11: Focus on Shock

11

Low Blood FlowHypovolemic Shock

Body response to acute volume loss depends on :

Extent of injury or insultAgeGeneral state of health

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 12: Focus on Shock

12

Low Blood FlowHypovolemic Shock

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 13: Focus on Shock

13

Distributive ShockNeurogenic Shock

Hemodynamic phenomenon that can occur within 30 minutes of a spinal cord injury at the fifth thoracic (T5) vertebra or above and can last up to 6 weeks

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 14: Focus on Shock

14

Distributive ShockNeurogenic Shock

Can occur in response to spinal anesthesia Results in massive vasodilation,

leading to pooling of blood in vessels

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 15: Focus on Shock

Pathophysiology of Neurogenic Shock

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 15

Fig. 67-4. The pathophysiology of neurogenic shock. BP, Blood pressure.

Page 16: Focus on Shock

16

Distributive ShockNeurogenic Shock

Clinical manifestations HypotensionBradycardia Temperature dysregulation (resulting

in heat loss)Dry skin Poikilothermia (taking on the

temperature of the environment)

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 17: Focus on Shock

17

Distributive ShockAnaphylactic Shock

Acute, life-threatening hypersensitivity reactionMassive vasodilationRelease of mediators ↑ capillary permeability

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 18: Focus on Shock

18

Distributive ShockAnaphylactic Shock

Clinical manifestationsAnxiety, confusion, dizziness Sense of impending doom Chest pain Incontinence

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 19: Focus on Shock

19

Distributive ShockAnaphylactic Shock

Clinical manifestations Swelling of the lips and tongue,

angioedemaWheezing, stridor Flushing, pruritus, urticariaRespiratory distress and circulatory

failure

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 20: Focus on Shock

20

Distributive ShockSeptic Shock

Sepsis: systemic inflammatory response to documented or suspected infection

Severe sepsis = Sepsis + Organ dysfunction

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 21: Focus on Shock

21

Distributive ShockSeptic Shock

Septic shock = Presence of sepsis with hypotension

despite fluid resuscitation Presence of tissue perfusion

abnormalities

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 22: Focus on Shock

Pathophysiology of Septic Shock

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 22

Fig. 67-5. The pathophysiology of septic shock. CNS, Central nervous system.

Page 23: Focus on Shock

23Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 24: Focus on Shock

24

Distributive ShockSeptic Shock

Clinical manifestations ↑ coagulation and inflammation ↓ fibrinolysis

Formation of microthrombi Obstruction of microvasculature

Hyperdynamic state: increased CO and decreased SVR

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 25: Focus on Shock

25

Distributive ShockSeptic Shock

Clinical manifestations (cont’d) Tachypnea/hyperventilation Temperature dysregulation ↓ urine outputAltered neurologic statusGI dysfunctionRespiratory failure is common.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 26: Focus on Shock

26

Obstructive Shock

Develops when physical obstruction to blood flow occurs with decreased CO From restriction to diastolic filling of

the right ventricle due to compressionAbdominal compartment syndrome

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 27: Focus on Shock

27

Obstructive Shock

Patient will experienceDecreased CO Increased afterloadVariable left ventricular filling

pressures

Rapid assessment and immediate treatment are important.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 28: Focus on Shock

28

Stages of Shock1. Initial Stage

Usually not clinically apparentMetabolism changes from aerobic to

anaerobic. Lactic acid accumulates and must be

removed by blood and broken down by liver.

Process requires unavailable O2.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 29: Focus on Shock

29

Stages of Shock2. Compensatory Stage

Clinically apparent NeuralHormonalBiochemical compensatory

mechanisms

Attempts are aimed at overcoming consequences of anaerobic metabolism and maintaining homeostasis.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 30: Focus on Shock

Compensatory Stage of Shock

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 30

Fig. 67-7. Compensatory stage: reversible stage during which compensatory mechanisms are

effective and homeostasis is maintained.

Page 31: Focus on Shock

31

Stages of Shock2. Compensatory Stage

Baroreceptors in carotid and aortic bodies activate SNS in response to ↓BP.Vasoconstriction while blood to vital

organs maintained

↓ blood to kidneys activates renin–angiotensin system ↑ venous return to heart, CO, BP

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 32: Focus on Shock

32

Stages of Shock2. Compensatory Stage

Impaired GI motilityRisk for paralytic ileus

Cool, clammy skin from blood Except septic patient who is warm and

flushed

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 33: Focus on Shock

33

Stages of Shock2. Compensatory Stage

Shunting blood from lungs increases physiologic dead space.

↓ arterial O2 levels Increase in rate/depth of respirations V/Q mismatch

SNS stimulation increases myocardial O2 demands.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 34: Focus on Shock

34

Stages of Shock2. Compensatory Stage

If perfusion deficit corrected, patient recovers with no residual sequelae

If deficit not corrected, patient enters progressive stage

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 35: Focus on Shock

35

Stages of Shock3. Progressive Stage

Begins when compensatory mechanisms fail

Aggressive interventions to prevent multiple organ dysfunction syndrome

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 36: Focus on Shock

Progressive Stage of Shock

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 36

Fig. 67-8. Progressive stage: compensatory mechanisms are becoming ineffective and

fail to maintain perfusion to vital organs.

Page 37: Focus on Shock

37

Stages of Shock3. Progressive Stage

Hallmarks of ↓ cellular perfusion and altered capillary permeability

Leakage of protein into interstitial space ↑ systemic interstitial edema

Anasarca Fluid leakage affects solid organs and

peripheral tissues. ↓ blood flow to pulmonary capillaries

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 38: Focus on Shock

38

Stages of Shock3. Progressive Stage

Movement of fluid from pulmonary vasculature to interstitium

Pulmonary edema Bronchoconstriction ↓ residual capacity

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 39: Focus on Shock

39

Stages of Shock3. Progressive Stage

Fluid moves into alveoli Edema Decreased surfactant Worsening V/Q mismatch Tachypnea Crackles Increased work of breathing

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 40: Focus on Shock

40

Stages of Shock3. Progressive Stage

CO begins to fall Decreased peripheral perfusion Hypotension Weak peripheral pulses Ischemia of distal extremities

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 41: Focus on Shock

41

Stages of Shock3. Progressive Stage

Myocardial dysfunction results in Dysrhythmias Ischemia Myocardial infarction End result: complete deterioration of

cardiovascular system

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 42: Focus on Shock

42

Stages of Shock3. Progressive Stage

Mucosal barrier of GI system becomes ischemic

Ulcers Bleeding Risk of translocation of bacteria Decreased ability to absorb nutrients

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 43: Focus on Shock

43

Stages of Shock3. Progressive Stage

Liver fails to metabolize drugs and waste.

Jaundice Elevated enzymes Loss of immune function Risk for DIC and significant bleeding

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 44: Focus on Shock

44

Stages of Shock4. Irreversible Stage

Exacerbation of anaerobic metabolism Accumulation of lactic acid ↑ capillary permeability

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 45: Focus on Shock

Irreversible Stage of Shock

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 45

Fig. 67-9. Irreversible or refractory stage: compensatory mechanisms are not functioning or are

totally ineffective, leading to multiple organ dysfunction syndrome.

Page 46: Focus on Shock

46

Stages of Shock4. Irreversible Stage

Profound hypotension and hypoxemia Tachycardia worsens. Failure of one organ system affects

others. Recovery unlikely

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 47: Focus on Shock

47

Diagnostic Studies

Thorough history and physical examination No single study to determine shock

Blood studies Elevation of lactate Base deficit

12-lead ECG Chest x-rayHemodynamic monitoring

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 48: Focus on Shock

48

Collaborative Care

Identify patients at risk Integration of the patient’s history, physical

examination, and clinical findings to establish a diagnosis

Interventions to control or eliminate the cause of decreased perfusion

Protection of target and distal organs from dysfunction

Provision of multisystem supportive care

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 49: Focus on Shock

49

Collaborative Care

General strategies Ensure patent airway.Maximize oxygen delivery.

Cornerstone of therapy for septic, hypovolemic, and anaphylactic shock = Volume expansion* Isotonic crystalloids (e.g., normal

saline) for initial resuscitation of shock

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 50: Focus on Shock

50Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 51: Focus on Shock

51

Collaborative Care

Volume expansion If the patient does not respond to 2 to

3 L of crystalloids, then blood administration and central venous monitoring may be instituted.

Complications of fluid resuscitation Hypothermia

Coagulopathy

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 52: Focus on Shock

52

Collaborative Care

Primary goal of drug therapy = Correction of decreased tissue perfusion Vasopressor drugs (e.g., norepinephrine)

Achieve/maintain MAP >60 to 65 mm Hg. Reserved for patients unresponsive to fluid

resuscitation

Vasodilator therapy (e.g., nitroglycerin, nitroprusside) Achieve/maintain MAP >65 mm Hg.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 53: Focus on Shock

53

Collaborative Care

Nutrition: vital to decreasing morbidity

from shock.

Initiate enteral nutrition within the first 24 hours.

Initiate parenteral nutrition if enteral feedings contraindicated or fail to meet at least 80% of caloric requirements

Monitor protein, nitrogen balance, BUN, glucose, electrolytes.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 54: Focus on Shock

54

Collaborative CareCardiogenic Shock

Restore blood flow to the myocardium by restoring the balance between O2supply & demand.

Thrombolytic therapy Angioplasty with stenting Emergency revascularization Valve replacement

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 55: Focus on Shock

55

Collaborative CareCardiogenic Shock

Hemodynamic monitoring Drug therapy (e.g., diuretics to

reduce preload) Circulatory assist devices (e.g.,

intraaortic balloon pump, ventricular assist device)

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 56: Focus on Shock

56

Collaborative CareHypovolemic Shock

Management focuses on stoppingthe loss of fluid and restoring the circulating volume.

Fluid replacement is calculated using a 3:1 rule: (3 mL of isotonic crystalloid for every 1

mL of estimated blood loss).

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 57: Focus on Shock

57

Collaborative CareSeptic Shock

Fluid replacement to restore perfusion Hemodynamic monitoring

Vasopressor drug therapy

Vasopressin for patients refractory to vasopressor therapy

IV corticosteroids if failed vasopressor therapy & fluid resuscitation, to maintain adequate BP

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 58: Focus on Shock

58

Collaborative Care Septic Shock

Antibiotics after cultures are obtained (e.g., blood, wound exudate, urine, stool, sputum)

Drotrecogin alfa (Xigris)Major side effect: bleeding

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 59: Focus on Shock

59

Collaborative Care Septic Shock

Glucose levels <150 mg/dL Stress ulcer prophylaxis with

histamine (H2)-receptor blockers Deep vein thrombosis prophylaxis

with low-dose unfractionated heparin or low-molecular-weight heparin

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 60: Focus on Shock

60

Collaborative CareNeurogenic Shock

In spinal cord injury: spinal stability

Tx hypotension and bradycardia with vasopressors and atropine

Fluids cautiouslyMonitor for hypothermia.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 61: Focus on Shock

61

Collaborative CareAnaphylactic Shock

Epinephrine, diphenhydramine Maintaining a patent airway

Nebulized bronchodilators Endotracheal intubation or

cricothyroidotomy may be necessary Aggressive fluid replacement Intravenous corticosteroids if significant

hypotension persists after 1 to 2 hours of aggressive therapy

.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 62: Focus on Shock

62

Collaborative CareObstructive Shock

Early recognition and treatment is primary strategy.Mechanical decompression Radiation or removal of mass Decompressive laparotomy

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 63: Focus on Shock

63

Nursing Assessment

ABCs: airway, breathing, and circulation

Focused assessment of tissue perfusion Vital signs Peripheral pulses Level of consciousness Capillary refill Skin (e.g., temperature, color, moisture) Urine output

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 64: Focus on Shock

64

Nursing Assessment

Brief history Events leading to shockOnset and duration of symptoms

Details of care received before hospitalization Allergies Vaccinations

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 65: Focus on Shock

65

Nursing Diagnoses

Ineffective tissue perfusion: renal, cerebral, cardiopulmonary, gastrointestinal, hepatic, and peripheral Fear Potential complication: organ

ischemia/dysfunction

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 66: Focus on Shock

66

Planning

Goals for patientAssurance of adequate tissue perfusionRestoration of normal or baseline BPReturn/recovery of organ functionAvoidance of complications from

prolonged states of hypoperfusion

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 67: Focus on Shock

67

Nursing Implementation

Health promotion Identify patients at risk.

Elderly patients Those with debilitating illness Those who are immunocompromised Surgical or accidental trauma patients

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 68: Focus on Shock

68

Nursing Implementation

Health promotion (cont’d)

Planning to prevent shock Monitoring fluid balance to prevent

hypovolemic shock Maintenance of hand washing to prevent

spread of infection

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 69: Focus on Shock

69

Nursing Implementation

Neurologic status: orientation and level of consciousness Cardiac status

Continuous ECG VS, capillary refillHemodynamic parameters: central

venous pressure, PA pressures, CO, PAWP

Heart sounds: murmurs, S3, S4

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 70: Focus on Shock

70

Nursing Implementation

Respiratory status Respiratory rate and rhythmBreath sounds Continuous pulse oximetry Arterial blood gases Most patients will be intubated and

mechanically ventilated.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 71: Focus on Shock

71

Nursing Implementation

Urine output Tympanic or pulmonary arterial

temperature Skin: temperature, pallor, flushing,

cyanosis, diaphoresis, piloerection Bowel sounds

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 72: Focus on Shock

72

Nursing Implementation

Nasogastric drainage/stools for occult blood I&O, fluid and electrolyte balance Oral care/hygiene based on O2

requirements Passive/active range of motion

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 73: Focus on Shock

73

Nursing Implementation

Assess level of anxiety and fear.Medication PRN Talk to patientVisit from clergy Family involvement Comfort measures Privacy Call light within reach

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 74: Focus on Shock

74

Evaluation

Normal or baseline, ECG, BP, CVP, and PAWP Normal temperatureWarm, dry skin Urinary output >0.5 mL/kg/hr Normal RR and SaO2 ≥90% Verbalization of fears, anxiety

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.